Methods: Exosomes were isolated from C2C12 myoblasts (MB), myotubes (MT) and ischaemic myotubes (IMT) through ultracentrifugation. Presence of exosomes was confirmed using Nanosight, western blotting and electron microscopy (EM). PKH26 labelled exosomes were cocultured with human umbilical vein endothelial cells (HUVECS) for 12 and 24hrs. Exosome uptake was assessed by fluorescent microscopy and FACs. The functional effect of IMT-exosomes on HUVECs was assessed through angiogenesis assays. Results: Nanosight data confirmed exosome populations of similar size and frequency secreted by MTs and IMTs (MT-exosome peak 107nm, concentration 4.85e+008AE 2.74e+007particles/ml IMT-exosome peak 98nm, concentration 6.08e+008AE1.68e+007particles/ml). EM and western blotting showed that MT-and IMT-exosomes are similar in structure and positive for known exosomal markers CD81 and Alix. Co-culture of 25ul exosomes with HUVECs resulted in uptake of MB-MT-and IMT-exosomes over 24hrs. Angiogenesis assay demonstrated that IMT-exosomes stimulate tube formation in a concentration dependent manner. Conclusion: Our data demonstrates that muscle exosomes are readily taken up by HUVECs, suggesting a novel method of muscle-vasculature intercellular communication. An ischaemic microenvironment alters the exosomal message, which in turn stimulates angiogenesis. In ischaemia, clarifying the role of exosomes in angiogenesis may provide novel targets that can be manipulated for patient benefit.
Introduction and Objectives: A role for Sphingosine-1phosphate receptors (S1PR) in atherosclerosis has been suggested from animal experiments but no data from humans are available. This study was designed to measure the expression of S1PR in various human vascular beds and to analyze potential associations between receptor expression and plaque burden. Methods: Tissue samples from 6 arteries (coronary a., CO, carotid a., CA, ascending aorta , AS, descending aorta, DE, abdominal aorta, AB, and iliac a., IL) were collected from randomly selected people (N¼163) during autopsies. For each subject, a comprehensive plaque score (CPS) was generated based on plaque in the arteries harvested. Expression of S1PR1-3 was measured by qPCR and data were expressed as log2. Statistical analyses were performed by appropriate non-parametric tests. Results: Among the 6 arteries, expression of each of the three S1PR measured differs significantly. The highest expression of all S1PR was measured in CO and the lowest in AS and DE. In all 6 arteries, the highest positive correlation was found between S1PR1 and S1PR2 expression with Spearman coefficients (r) between 0.59 (P¼2xE-17) in IL and 0.74 (P¼1xE-29) in AS. When the expression of S1PR was compared between the different arteries, the most significant associations were always found for S1PR3. Most strikingly, subjects with increasing CPS show a considerable decrease in S1PR3 expression in all arteries, which is independent of age. Interestingly, S1PR3 expression also decreases with increasing CPS even in arteries that themselves were scored healthy.
Conclusion: Loss of S1PR3 expression is associated with increasing plaque burden. This effect appears to be of systemic nature as also arteries are concerned that themselves are free of plaque. This finding underlines the systemic nature of atherosclerosis and identifies the S1P/S1PR3-axis as a potential target to slow progression of atherosclerosis in humans.
Nicotine Regulates Segmental Aortic Stiffening
Markus Wagenhäuser a,b , Isabel Schellinger a,b , Joshua Spin a,b , Hubert Schelzig a,b , Philip S. Tsao a,b a Heinrich-Heine-University Düsseldorf, Germany b Stanford University School of Medicine, USA Introduction: Vascular stiffness and aortic stiffness in particular contributes to the development of AAA. Differential segment-specific stiffness development, quantified via the "segmental aortic stiffness (SAS)"-gradient, in adjacent segments may be a major contributor. Nicotine is the major risk factor for AAA development. This study investigates how nicotine influences stiffness development in the abdominal (AS) and thoracic (TS) segment. Methods: Wildtype-mice (C57BL/6) were infused with nicotine for 40 days using osmotic mini pumps (20mg/KG/ day). Segmental aortic stiffness was analyzed using M-mode and pulse-wave velocity (PWV) ultrasound measurements. Thereafter, explanted aortae were used for myograph measurements and stiffness-related gene expression (Matrix-Metalloproteinase (MMP)-2, MMP-9, Col1A1, Col3A1) was analyzed. Results: Aortic PWV increased with nicotine (p<.05). In particular, stiffening for the AS occurred after 10 days (p<.05), while increase in aortic stiffness for the TS was only found after 40 days (p<.05). SAS was enhanced with nicotine vs. PBS for both time points. Stiffness-related genes were up-regulated after 40 days in both segments (p<.05). Discussion: Aortic stiffening is different for the TS and AS over a 40-day time course. SAS is enhanced with nicotine infusion based on stiffness-related gene expression. The TS has a higher capacity to withstand aortic stiffening, although the reason remains uncertain. Differences in stiffness development for the TS and AS may in part explain nicotine's role in promoting AAA. 
